Ligand Pharmaceuticals Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Net Income	6,561	5,141	4,132	3,438	7,141	4,954	Upgrade
Depreciation & Amortization	469.9	464.2	451.6	387.4	347.7	430.3	Upgrade
Other Amortization	209.7	209.7	208.6	184.8	200.7	236.3	Upgrade
Other Operating Activities	-553.5	-1,583	68.2	-1,748	-662.7	1,714	Upgrade
Operating Cash Flow	6,686	4,232	4,860	2,262	7,027	7,335	Upgrade
Operating Cash Flow Growth	124.26%	-12.93%	114.83%	-67.81%	-4.20%	-	Upgrade
Capital Expenditures	-306.3	-419.7	-717.3	-565.1	-532.6	-513.2	Upgrade
Purchase / Sale of Intangible Assets	-23.1	-	-	5.2	-	-	Upgrade
Cash Acquisitions	-448.4	-27.9	-311.6	-	-867	-	Upgrade
Other Investing Activities	-	-	-	0.1	-	-	Upgrade
Investing Cash Flow	-777.8	-447.6	-1,029	2,753	-1,400	-513.2	Upgrade
Long-Term Debt Issued	-	975.7	358.5	-	864.2	-	Upgrade
Total Debt Repaid	-345.3	-202.2	-189.4	-233.1	-173.4	-224.4	Upgrade
Net Debt Issued (Repaid)	201.6	773.5	169.1	-233.1	690.8	-224.4	Upgrade
Issuance of Common Stock	-	796.8	-	-	200	-	Upgrade
Repurchases of Common Stock	-25.4	-24.7	-20.7	-22.3	-23.4	-13	Upgrade
Common Dividends Paid	-5,145	-4,505	-4,197	-3,850	-6,945	-6,171	Upgrade
Other Financing Activities	-31.1	-39.2	-32	-71.4	-29.2	-29.8	Upgrade
Financing Cash Flow	-5,000	-2,999	-4,080	-4,177	-6,107	-6,439	Upgrade
Foreign Exchange Rate Adjustments	15.6	-7.2	35.5	8.3	-33.5	58.6	Upgrade
Miscellaneous Cash Flow Adjustments	-78.4	-78.4	-	-0.1	-	0.1	Upgrade
Net Cash Flow	845.7	699.5	-213.3	847.1	-513.1	441.6	Upgrade
Free Cash Flow	6,380	3,812	4,143	1,697	6,494	6,822	Upgrade
Free Cash Flow Growth	153.74%	-7.99%	144.10%	-73.87%	-4.80%	-	Upgrade
Free Cash Flow Margin	14.36%	9.09%	11.00%	5.24%	19.41%	23.04%	Upgrade
Free Cash Flow Per Share	12.94	7.62	8.28	3.39	12.99	13.64	Upgrade
Cash Interest Paid	32	39.2	32	71.4	29.5	29.9	Upgrade
Cash Income Tax Paid	1,425	1,471	1,998	1,789	1,933	1,185	Upgrade
Levered Free Cash Flow	2,514	711.9	-23,963	-39,159	1,972	7,349	Upgrade
Unlevered Free Cash Flow	2,896	1,160	-23,711	-38,933	2,140	7,484	Upgrade

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.